| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | Brazil | 1 | |
| #7 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Environmental technology | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Climate change adaptation technologies | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Nykjaer Anders | 6 |
| #2 | Willnow Thomas | 2 |
| #3 | Thinggaard Jacob | 2 |
| #4 | Boye Soeren Valdgaard | 2 |
| #5 | Anders Nykjar | 1 |
| #6 | Nykj R Anders | 1 |
| #7 | Pedersen Anders Hjelholt | 1 |
| #8 | Hejnaes Kim | 1 |
| #9 | Nykjaer Andres | 1 |
| #10 | Anders Nykjaer | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2009132660A1 | Agents binding to megalin or sex hormone binding globulin and compositions therof for treatment of steroid dependent cancers | |
| EP2139461A2 | Amino derivatives to prevent nephrotoxicity and cancer | |
| EP1809381A2 | Use of compounds for the prevention of drug-induced cell toxicity | |
| CN1794982A | Use of compounds for the prevention of drug-induced cell toxicity | |
| AU2002307802A8 | Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents |